SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-07-108350
Filing Date
2007-05-09
Accepted
2007-05-09 17:01:15
Documents
6
Period of Report
2007-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d10q.htm 10-Q 319123
2 AGREEMENT OF PURCHASE AND SALE, DATED MAY 9, 2007 dex101.htm EX-10.1 171892
3 AGREEMENT OF PURCHASE AND SALE, DATED MAY 9, 2007 dex102.htm EX-10.2 80458
4 SECTION 302 CEO CERTIFICATION dex311.htm EX-31.1 9200
5 SECTION 302 CFO CERTIFICATION dex312.htm EX-31.2 9467
6 SECTION 906 CEO AND CFO CERTIFICATION dex32.htm EX-32 5531
  Complete submission text file 0001193125-07-108350.txt   596989
Mailing Address
Business Address 420 CHIPETA WAY STE 240 SALT LAKE CITY UT 84108-1256 8015834939
NPS PHARMACEUTICALS INC (Filer) CIK: 0000890465 (see all company filings)

IRS No.: 870439579 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-23272 | Film No.: 07833270
SIC: 2836 Biological Products, (No Diagnostic Substances)